BlackRock’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.71M Sell
1,090,863
-2,381,893
-69% -$5.91M ﹤0.01% 3912
2025
Q1
$5.38M Sell
3,472,756
-46,389
-1% -$71.9K ﹤0.01% 3579
2024
Q4
$7.53M Buy
3,519,145
+21,379
+0.6% +$45.8K ﹤0.01% 3513
2024
Q3
$15.2M Buy
3,497,766
+280,638
+9% +$1.22M ﹤0.01% 3157
2024
Q2
$15M Buy
3,217,128
+1,836,606
+133% +$8.56M ﹤0.01% 3102
2024
Q1
$7M Buy
1,380,522
+30,475
+2% +$155K ﹤0.01% 3480
2023
Q4
$3.79M Sell
1,350,047
-50,058
-4% -$141K ﹤0.01% 3727
2023
Q3
$4.02M Sell
1,400,105
-105,334
-7% -$302K ﹤0.01% 3679
2023
Q2
$7.6M Buy
1,505,439
+749,052
+99% +$3.78M ﹤0.01% 3470
2023
Q1
$1.43M Sell
756,387
-237,382
-24% -$449K ﹤0.01% 4125
2022
Q4
$1.79M Sell
993,769
-269,748
-21% -$486K ﹤0.01% 4101
2022
Q3
$2.14M Sell
1,263,517
-8,595
-0.7% -$14.5K ﹤0.01% 4083
2022
Q2
$3.13M Sell
1,272,112
-1,057,052
-45% -$2.6M ﹤0.01% 3953
2022
Q1
$6.45M Buy
2,329,164
+80,697
+4% +$224K ﹤0.01% 3739
2021
Q4
$12M Buy
2,248,467
+57,837
+3% +$308K ﹤0.01% 3502
2021
Q3
$18.5M Buy
2,190,630
+36,418
+2% +$308K ﹤0.01% 3276
2021
Q2
$26.3M Buy
2,154,212
+223,627
+12% +$2.73M ﹤0.01% 3083
2021
Q1
$46.8M Buy
1,930,585
+257,447
+15% +$6.25M ﹤0.01% 2622
2020
Q4
$53.6M Buy
1,673,138
+575,818
+52% +$18.5M ﹤0.01% 2379
2020
Q3
$33.2M Buy
1,097,320
+344,952
+46% +$10.4M ﹤0.01% 2483
2020
Q2
$31.7M Buy
752,368
+184,680
+33% +$7.79M ﹤0.01% 2505
2020
Q1
$14.2M Buy
+567,688
New +$14.2M ﹤0.01% 2753